Psilocybin-assisted therapy

PS2025PsilocybinPsilocybin-assisted therapyPsychedelic Assisted Therapy

Psilocybin-assisted psychotherapy for Generalized Anxiety Disorder: safety and efficacy in a world-first randomized controlled trial

Jamila Hokanson, Paul Liknaitzky

PS2025PsilocybinPsilocybin-assisted therapyPsychedelic Assisted Therapy

Psilocybin-Therapy for Anorexia Nervosa: Safety, Clinical Outcomes, and Moderators of Response

Jamila Hokanson, Hannah Douglass

PS2025PsilocybinPsilocybin-assisted therapyPsychedelic Assisted Therapy

Psilocybin-assisted therapy + Mindfulness Based Stress Reduction (MBSR) for front-line healthcare provider COVID-19 related depression and burnout

Anthony L Back, Benjamin Lewis

PS2025PsilocybinPsilocybin-assisted therapyPsychedelic Assisted Therapy

A Phase 1/2 study of group retreat psilocybin therapy for metastatic cancer identifies a safe ratio of facilitators to participants

Anthony L Back

PS2025PsilocybinPsilocybin-assisted therapyPsychedelic Assisted Therapy

Psilocybin-assisted Therapy To Enhance Physician Well-being And Reduce Burnout

Anthony L Back, Kush Bhatt

PS2025PsilocybinPsilocybin-assisted therapyPsychedelic Assisted TherapyVeterans

Safety and efficacy of psilocybin-assisted psychotherapy for US military Veterans with PTSD

Stacey Armstrong

PS2025PsilocybinPsilocybin-assisted therapyPsychedelic Assisted Therapy

Psilocybin therapy in patients with fibromyalgia: mechanisms and brain biomarkers of action

Franklin King, James Close

PS2025PsilocybinPsilocybin-assisted therapyPsychedelic Assisted Therapy

Psilocybin-Assisted Therapy for Irritable Bowel Syndrome: Rationale, Design, and Preliminary Results & upcoming MGH fibromyalgia study

Franklin King, Erin Mauney

PS2025PsilocybinPsilocybin-assisted therapyPsychedelic Assisted Therapy

Exploring New Frontiers: Psilocybin Therapy for mood dysfunction in Parkinson’s Disease

Franklin King, Ellen Bradley

PS2025PsilocybinPsilocybin-assisted therapyPsychedelic Assisted Therapy

Transdiagnostic Outcomes from Yale's Real-World Psilocybin Trial: Connecticut-Funded Pioneering Psychedelic Therapy Program and Insights from Other State Initiatives

Gabrielle Agin-Liebes, Jesse MacLachlan